Genomic Health, Inc.

Genomic Health, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. Genomic Health, Inc. is not very popular among insiders. Genomic Health, Inc. is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze t...

News